bladder cancer

An arrow incrementally going up stairs before pointing straight up Blue background
Pharma

Keytruda, Padcev keep winning streak in bladder cancer

The PD-1/ADC combo showed an overall survival benefit as a perioperative treatment in patients with cisplatin-eligible muscle-invasive bladder cancer.
Angus Liu Dec 17, 2025 9:53am
On target clinical trial success bullseye score

ImmunityBio's Anktiva hits the mark in bladder cancer subtype

Dec 17, 2025 9:35am
FDA

Padcev, Keytruda combo scores game-changing FDA nod

Nov 21, 2025 1:22pm
On target clinical trial success bullseye score

Keytruda, Padcev cut risk of death by 50% in MIBC patient subset

Oct 18, 2025 10:30am
Imfinzi

AZ's Imfinzi looks set up for another bladder cancer expansion

Oct 17, 2025 8:10am
JNJ

J&J's Joaquin Duato 'optimistic' amid MFN discussions with Trump

Oct 14, 2025 11:52am